| 1 | Rare germline genetic variation in PAX8 transcription factor binding sites and susceptibility to epithelial ovarian cancer | 3.3 | 0 | Citations (PDF) |
| 2 | Polygenic risk scores stratify breast cancer risk among women with benign breast disease | 4.6 | 3 | Citations (PDF) |
| 3 | Characterizing somatic mutations in ovarian cancer germline risk regions | 4.4 | 0 | Citations (PDF) |
| 4 | Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors | 4.0 | 13 | Citations (PDF) |
| 5 | An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy | 6.4 | 21 | Citations (PDF) |
| 6 | Novel breast cancer susceptibility loci under linkage peaks identified in African ancestry consortia | 2.9 | 1 | Citations (PDF) |
| 7 | Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis | 3.0 | 8 | Citations (PDF) |
| 8 | Risk Factors for Ovarian Cancer by
BRCA
Status: A Collaborative Case-Only Analysis | 1.1 | 7 | Citations (PDF) |
| 9 | Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease | 4.3 | 5 | Citations (PDF) |
| 10 | Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes | 13.7 | 15 | Citations (PDF) |
| 11 | Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions | 6.5 | 15 | Citations (PDF) |
| 12 | Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium | 3.3 | 7 | Citations (PDF) |
| 13 | Concurrent RB1 Loss and
BRCA
Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma | 6.8 | 9 | Citations (PDF) |
| 14 | Understanding the genetic complexity of puberty timing across the allele frequency spectrum | 25.2 | 34 | Citations (PDF) |
| 15 | Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK Biobank | 5.5 | 8 | Citations (PDF) |
| 16 | High-resolution functional mapping of RAD51C by saturation genome editingCell, 2024, 187, 5719-5734.e19 | 33.7 | 24 | Citations (PDF) |
| 17 | Profiling the immune landscape in mucinous ovarian carcinoma | 3.0 | 23 | Citations (PDF) |
| 18 | Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery | 3.0 | 2 | Citations (PDF) |
| 19 | CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study | 4.0 | 33 | Citations (PDF) |
| 20 | Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort | 1.1 | 5 | Citations (PDF) |
| 21 | Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response | 1.1 | 4 | Citations (PDF) |
| 22 | FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women | 3.0 | 10 | Citations (PDF) |
| 23 | Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis | 4.8 | 20 | Citations (PDF) |
| 24 | Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry | 9.6 | 12 | Citations (PDF) |
| 25 | Evaluation and comparison of different breast cancer prognosis scores based on gene expression data | 4.8 | 20 | Citations (PDF) |
| 26 | The impact of coding germline variants on contralateral breast cancer risk and survival | 6.5 | 18 | Citations (PDF) |
| 27 | Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility | 6.6 | 10 | Citations (PDF) |
| 28 | Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions | 4.6 | 29 | Citations (PDF) |
| 29 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study | 3.3 | 17 | Citations (PDF) |
| 30 | Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2 | 5.5 | 15 | Citations (PDF) |
| 31 | PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants | 6.4 | 7 | Citations (PDF) |
| 32 | Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis | 7.6 | 31 | Citations (PDF) |
| 33 | Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases | 3.8 | 1 | Citations (PDF) |
| 34 | Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses | 5.5 | 12 | Citations (PDF) |
| 35 | Association of the
CHEK2
c.
1100delC
variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival | 2.6 | 5 | Citations (PDF) |
| 36 | Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility | 1.1 | 10 | Citations (PDF) |
| 37 | Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel | 3.8 | 3 | Citations (PDF) |
| 38 | Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes | 0.9 | 5 | Citations (PDF) |
| 39 | A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry | 4.8 | 12 | Citations (PDF) |
| 40 | Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk | 25.2 | 45 | Citations (PDF) |
| 41 | Polygenic scores in cancer | 60.8 | 35 | Citations (PDF) |
| 42 | Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer | 5.3 | 5 | Citations (PDF) |
| 43 | Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations | 13.7 | 20 | Citations (PDF) |
| 44 | Meta-analysis of the association between emphysematous change on thoracic computerized tomography scan and recurrent pneumothorax | 0.5 | 3 | Citations (PDF) |
| 45 | Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors | 3.8 | 54 | Citations (PDF) |
| 46 | High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival | 1.1 | 6 | Citations (PDF) |
| 47 | Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer | 6.5 | 15 | Citations (PDF) |
| 48 | Reproductive Factors Do Not Influence Survival with Ovarian Cancer | 1.1 | 2 | Citations (PDF) |
| 49 | Rare germline copy number variants (CNVs) and breast cancer risk | 4.4 | 12 | Citations (PDF) |
| 50 | Polygenic risk modeling for prediction of epithelial ovarian cancer risk | 3.0 | 56 | Citations (PDF) |
| 51 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes | 4.8 | 26 | Citations (PDF) |
| 52 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes | 14.4 | 101 | Citations (PDF) |
| 53 | Validated biomarker assays confirm that
ARID1A
loss is confounded with
MMR
deficiency,
CD8
+
TIL
infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas | 4.9 | 39 | Citations (PDF) |
| 54 | Large-scale Integrated Analysis of Genetics and Metabolomic Data Reveals Potential Links Between Lipids and Colorectal Cancer Risk | 1.1 | 4 | Citations (PDF) |
| 55 | A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes | 6.6 | 44 | Citations (PDF) |
| 56 | Germline BRCA variants, lifestyle and ovarian cancer survival | 3.0 | 8 | Citations (PDF) |
| 57 | A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women | 2.8 | 10 | Citations (PDF) |
| 58 | Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci | 4.8 | 23 | Citations (PDF) |
| 59 | Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region | 1.1 | 14 | Citations (PDF) |
| 60 | Genetic Regulation of DNA Methylation Yields Novel Discoveries in GWAS of Colorectal Cancer | 1.1 | 4 | Citations (PDF) |
| 61 | Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach | 2.9 | 21 | Citations (PDF) |
| 62 | Relevance of the MHC region for breast cancer susceptibility in Asians | 2.0 | 2 | Citations (PDF) |
| 63 | Breast cancer risks associated with missense variants in breast cancer susceptibility genes | 9.6 | 51 | Citations (PDF) |
| 64 | Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies | 4.6 | 38 | Citations (PDF) |
| 65 | eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma | 1.1 | 7 | Citations (PDF) |
| 66 | Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes | 6.8 | 67 | Citations (PDF) |
| 67 | chromMAGMA: regulatory element-centric interrogation of risk variants | 2.6 | 3 | Citations (PDF) |
| 68 | No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity | 1.5 | 5 | Citations (PDF) |
| 69 | Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry | 3.8 | 3 | Citations (PDF) |
| 70 | Germline allelic expression of genes at 17q22 locus associates with risk of breast cancer | 4.9 | 2 | Citations (PDF) |
| 71 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model | 4.9 | 17 | Citations (PDF) |
| 72 | Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study | 10.6 | 61 | Citations (PDF) |
| 73 | Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis | 5.5 | 15 | Citations (PDF) |
| 74 | Enhancing the BOADICEA cancer risk prediction model to incorporate new data on
RAD51C
,
RAD51D
,
BARD1
updates to tumour pathology and cancer incidence | 3.8 | 61 | Citations (PDF) |
| 75 | Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction | 6.5 | 16 | Citations (PDF) |
| 76 | PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients | 4.8 | 14 | Citations (PDF) |
| 77 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci | 4.6 | 13 | Citations (PDF) |
| 78 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes | 6.8 | 16 | Citations (PDF) |
| 79 | Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study | 5.5 | 5 | Citations (PDF) |
| 80 | Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics | 6.5 | 28 | Citations (PDF) |
| 81 | The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer | 25.2 | 96 | Citations (PDF) |
| 82 | Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries | 25.2 | 194 | Citations (PDF) |
| 83 | Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk | 4.6 | 54 | Citations (PDF) |
| 84 | Population-based targeted sequencing of 54 candidate genes identifies
PALB2
as a susceptibility gene for high-grade serous ovarian cancer | 3.8 | 44 | Citations (PDF) |
| 85 | Common Susceptibility Loci for Male Breast Cancer | 4.6 | 20 | Citations (PDF) |
| 86 | Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies | 4.6 | 17 | Citations (PDF) |
| 87 | Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects | 0.9 | 60 | Citations (PDF) |
| 88 | Genetically predicted circulating protein biomarkers and ovarian cancer risk | 3.0 | 25 | Citations (PDF) |
| 89 | A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization | 13.7 | 54 | Citations (PDF) |
| 90 | CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers | 5.5 | 8 | Citations (PDF) |
| 91 | A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | 13.7 | 37 | Citations (PDF) |
| 92 | Genetic architectures of proximal and distal colorectal cancer are partly distinct | 16.8 | 71 | Citations (PDF) |
| 93 | Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women | 34.6 | 956 | Citations (PDF) |
| 94 | Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response | 3.8 | 43 | Citations (PDF) |
| 95 | Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer | 6.6 | 55 | Citations (PDF) |
| 96 | Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry | 4.6 | 66 | Citations (PDF) |
| 97 | Response to Li and Hopper | 6.5 | 5 | Citations (PDF) |
| 98 | Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? | 3.8 | 8 | Citations (PDF) |
| 99 | Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research | 2.8 | 9 | Citations (PDF) |
| 100 | Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer | 1.6 | 10 | Citations (PDF) |
| 101 | Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer | 1.1 | 9 | Citations (PDF) |
| 102 | Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women | 13.7 | 44 | Citations (PDF) |
| 103 | A systematic review assessing the existence of pneumothorax-only variants of FLCN. Implications for lifelong surveillance of renal tumours | 3.0 | 20 | Citations (PDF) |
| 104 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element | 6.5 | 7 | Citations (PDF) |
| 105 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus | 2.9 | 32 | Citations (PDF) |
| 106 | Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals | 1.6 | 12 | Citations (PDF) |
| 107 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment | 4.8 | 19 | Citations (PDF) |
| 108 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk | 5.5 | 18 | Citations (PDF) |
| 109 | Genetic insights into biological mechanisms governing human ovarian ageing | 37.9 | 343 | Citations (PDF) |
| 110 | Genomic risk prediction of coronary artery disease in women with breast cancer: a prospective cohort study | 4.8 | 10 | Citations (PDF) |
| 111 | Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial | 2.1 | 15 | Citations (PDF) |
| 112 | Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium | 1.1 | 35 | Citations (PDF) |
| 113 | A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer | 1.1 | 18 | Citations (PDF) |
| 114 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis | 3.4 | 3 | Citations (PDF) |
| 115 | Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study | 4.5 | 8 | Citations (PDF) |
| 116 | MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma | 2.9 | 16 | Citations (PDF) |
| 117 | Multi-omic machine learning predictor of breast cancer therapy response | 37.9 | 502 | Citations (PDF) |
| 118 | Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy | 4.6 | 94 | Citations (PDF) |
| 119 | Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent | 4.6 | 48 | Citations (PDF) |
| 120 | A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma | 4.3 | 80 | Citations (PDF) |
| 121 | Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium | 4.9 | 25 | Citations (PDF) |
| 122 | Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk | 4.3 | 24 | Citations (PDF) |
| 123 | Identification of novel epithelial ovarian cancer loci in women of African ancestry | 4.3 | 29 | Citations (PDF) |
| 124 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes | 25.2 | 166 | Citations (PDF) |
| 125 | Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer | 0.9 | 168 | Citations (PDF) |
| 126 | A Mendelian randomization analysis of circulating lipid traits and breast cancer risk | 4.9 | 71 | Citations (PDF) |
| 127 | Identification of Novel Loci and New Risk Variant in Known Loci for Colorectal Cancer Risk in East Asians | 1.1 | 42 | Citations (PDF) |
| 128 | Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families | 16.9 | 383 | Citations (PDF) |
| 129 | Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus | 6.0 | 22 | Citations (PDF) |
| 130 | Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites | 6.5 | 26 | Citations (PDF) |
| 131 | Breast cancer risk factors and their effects on survival: a Mendelian randomisation study | 7.1 | 86 | Citations (PDF) |
| 132 | Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk | 6.5 | 187 | Citations (PDF) |
| 133 | European polygenic risk score for prediction of breast cancer shows similar performance in Asian women | 13.7 | 118 | Citations (PDF) |
| 134 | Cancer therapy shapes the fitness landscape of clonal hematopoiesis | 25.2 | 634 | Citations (PDF) |
| 135 | Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer | 3.8 | 35 | Citations (PDF) |
| 136 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk | 6.5 | 56 | Citations (PDF) |
| 137 | Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses | 7.1 | 43 | Citations (PDF) |
| 138 | Sex-Specific Genetic Associations for Barrett’s Esophagus and Esophageal Adenocarcinoma | 0.9 | 22 | Citations (PDF) |
| 139 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses | 25.2 | 437 | Citations (PDF) |
| 140 | Prognostic gene expression signature for high-grade serous ovarian cancer | 10.0 | 125 | Citations (PDF) |
| 141 | Usual physical activity and subsequent hospital usage over 20 years in a general population: the EPIC-Norfolk cohort | 3.3 | 16 | Citations (PDF) |
| 142 | The effect of sample size on polygenic hazard models for prostate cancer | 3.0 | 14 | Citations (PDF) |
| 143 | Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe) | 7.1 | 13 | Citations (PDF) |
| 144 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement | 70.8 | 331 | Citations (PDF) |
| 145 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk | 3.4 | 4 | Citations (PDF) |
| 146 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE) | 6.8 | 70 | Citations (PDF) |
| 147 | Household Fuel Use and the Risk of Gastrointestinal Cancers: The Golestan Cohort Study | 8.4 | 31 | Citations (PDF) |
| 148 | Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium | 5.5 | 60 | Citations (PDF) |
| 149 | Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk | 1.1 | 35 | Citations (PDF) |
| 150 | Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants | 13.7 | 74 | Citations (PDF) |
| 151 | Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk | 2.6 | 9 | Citations (PDF) |
| 152 | A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data | 1.1 | 31 | Citations (PDF) |
| 153 | Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival | 3.0 | 24 | Citations (PDF) |
| 154 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers | 13.7 | 118 | Citations (PDF) |
| 155 | Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D | 4.6 | 148 | Citations (PDF) |
| 156 | Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status | 3.1 | 42 | Citations (PDF) |
| 157 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis | 13.7 | 35 | Citations (PDF) |
| 158 | Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study | 13.4 | 92 | Citations (PDF) |
| 159 | Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts | 2.4 | 19 | Citations (PDF) |
| 160 | Combining measures of immune infiltration shows additive effect on survival prediction in high-grade serous ovarian carcinoma | 5.5 | 27 | Citations (PDF) |
| 161 | Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility | 25.2 | 205 | Citations (PDF) |
| 162 | Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses | 4.8 | 34 | Citations (PDF) |
| 163 | Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic | 10.0 | 467 | Citations (PDF) |
| 164 | Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis | 13.7 | 547 | Citations (PDF) |
| 165 | Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk | 3.8 | 56 | Citations (PDF) |
| 166 | Novel Common Genetic Susceptibility Loci for Colorectal Cancer | 4.6 | 155 | Citations (PDF) |
| 167 | Sex specific associations in genome wide association analysis of renal cell carcinoma | 3.0 | 36 | Citations (PDF) |
| 168 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer | 6.4 | 42 | Citations (PDF) |
| 169 | Two truncating variants in FANCC and breast cancer risk | 3.4 | 6 | Citations (PDF) |
| 170 | Evidence of a Causal Association Between Cancer and Alzheimer’s Disease: a Mendelian Randomization Analysis | 3.4 | 43 | Citations (PDF) |
| 171 | Understanding of prognosis in non-metastatic prostate cancer: a randomised comparative study of clinician estimates measured against the PREDICT prostate prognostic model | 5.5 | 18 | Citations (PDF) |
| 172 | Shared heritability and functional enrichment across six solid cancers | 13.7 | 106 | Citations (PDF) |
| 173 | Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review | 1.9 | 20 | Citations (PDF) |
| 174 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases | 4.8 | 75 | Citations (PDF) |
| 175 | The functional <i>ALDH2</i> polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium | 1.6 | 10 | Citations (PDF) |
| 176 | Association analyses identify 31 new risk loci for colorectal cancer susceptibility | 13.7 | 218 | Citations (PDF) |
| 177 | Evaluation of vitamin D biosynthesis and pathway target genes reveals <i>UGT2A1/2</i> and <i>EGFR</i> polymorphisms associated with epithelial ovarian cancer in African American Women | 2.6 | 8 | Citations (PDF) |
| 178 | A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants | 25.2 | 125 | Citations (PDF) |
| 179 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer | 13.7 | 116 | Citations (PDF) |
| 180 | Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women | 3.0 | 43 | Citations (PDF) |
| 181 | Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model | 8.1 | 64 | Citations (PDF) |
| 182 | Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups | 37.9 | 350 | Citations (PDF) |
| 183 | Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer | 4.8 | 72 | Citations (PDF) |
| 184 | Body mass index and the association between low-density lipoprotein cholesterol as predicted by HMGCR genetic variants and breast cancer risk | 4.9 | 5 | Citations (PDF) |
| 185 | No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study | 6.0 | 19 | Citations (PDF) |
| 186 | Genome-wide association study of germline variants and breast cancer-specific mortality | 5.5 | 62 | Citations (PDF) |
| 187 | The association between weight at birth and breast cancer risk revisited using Mendelian randomisation | 5.3 | 17 | Citations (PDF) |
| 188 | Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer | 2.9 | 50 | Citations (PDF) |
| 189 | Prediction and clinical utility of a contralateral breast cancer risk model | 4.8 | 30 | Citations (PDF) |
| 190 | Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study | 8.1 | 75 | Citations (PDF) |
| 191 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes | 6.5 | 989 | Citations (PDF) |
| 192 | Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphomaBlood, 2019, 133, 1130-1139 | 4.2 | 38 | Citations (PDF) |
| 193 | European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer | 4.9 | 17 | Citations (PDF) |
| 194 | Mendelian randomization analysis of C-reactive protein on colorectal cancer risk | 4.9 | 45 | Citations (PDF) |
| 195 | BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors | 4.2 | 592 | Citations (PDF) |
| 196 | Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use | 5.4 | 84 | Citations (PDF) |
| 197 | Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus | 3.8 | 29 | Citations (PDF) |
| 198 | A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome‐wide significant common variants | 4.3 | 17 | Citations (PDF) |
| 199 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis | 4.9 | 91 | Citations (PDF) |
| 200 | Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci | 7.8 | 107 | Citations (PDF) |
| 201 | MyD88 and TLR4 Expression in Epithelial Ovarian Cancer | 3.7 | 28 | Citations (PDF) |
| 202 | The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers | 4.6 | 113 | Citations (PDF) |
| 203 | Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation | 4.3 | 27 | Citations (PDF) |
| 204 | Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study | 5.5 | 18 | Citations (PDF) |
| 205 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses | 2.6 | 79 | Citations (PDF) |
| 206 | Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia | 13.7 | 70 | Citations (PDF) |
| 207 | Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath | 6.8 | 17 | Citations (PDF) |
| 208 | Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women | 4.6 | 161 | Citations (PDF) |
| 209 | Determining Risk of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants | 0.9 | 75 | Citations (PDF) |
| 210 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium | 4.9 | 95 | Citations (PDF) |
| 211 | Use of deep whole-genome sequencing data to identify structure risk variants in breast cancer susceptibility genes | 2.9 | 22 | Citations (PDF) |
| 212 | Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study | 1.1 | 29 | Citations (PDF) |
| 213 | Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study | 4.9 | 18 | Citations (PDF) |
| 214 | Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study | 22.9 | 94 | Citations (PDF) |
| 215 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium | 3.4 | 57 | Citations (PDF) |
| 216 | Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus | 6.0 | 19 | Citations (PDF) |
| 217 | Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence | 3.3 | 9 | Citations (PDF) |
| 218 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry | 13.7 | 52 | Citations (PDF) |
| 219 | Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma | 13.7 | 106 | Citations (PDF) |
| 220 | Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphomaBlood, 2018, 132, 2040-2052 | 4.2 | 21 | Citations (PDF) |
| 221 | Alcohol consumption and future hospital usage: The EPIC-Norfolk prospective population study | 2.3 | 3 | Citations (PDF) |
| 222 | Pre-operative stromal stiffness measured by shear wave elastography is independently associated with breast cancer-specific survival | 2.4 | 32 | Citations (PDF) |
| 223 | Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study | 3.8 | 49 | Citations (PDF) |
| 224 | Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer | 14.4 | 258 | Citations (PDF) |
| 225 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study | 3.3 | 87 | Citations (PDF) |
| 226 | A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk | 3.8 | 64 | Citations (PDF) |
| 227 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility | 2.3 | 11 | Citations (PDF) |
| 228 | Identification of nine new susceptibility loci for endometrial cancer | 13.7 | 265 | Citations (PDF) |
| 229 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology | 4.4 | 3 | Citations (PDF) |
| 230 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci | 25.2 | 848 | Citations (PDF) |
| 231 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants | 13.7 | 103 | Citations (PDF) |
| 232 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer | 25.2 | 226 | Citations (PDF) |
| 233 | Discovery of common and rare genetic risk variants for colorectal cancer | 25.2 | 499 | Citations (PDF) |
| 234 | Weibull regression with Bayesian variable selection to identify prognostic tumour markers of breast cancer survival | 1.7 | 28 | Citations (PDF) |
| 235 | Dietary Protein Sources and All-Cause and Cause-Specific Mortality: The Golestan Cohort Study in Iran | 3.2 | 60 | Citations (PDF) |
| 236 | Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci | 5.5 | 26 | Citations (PDF) |
| 237 | Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies | 4.3 | 32 | Citations (PDF) |
| 238 | BRCA2
Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer | 3.8 | 87 | Citations (PDF) |
| 239 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk | 25.2 | 514 | Citations (PDF) |
| 240 | Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years | 4.9 | 47 | Citations (PDF) |
| 241 | Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial | 10.0 | 42 | Citations (PDF) |
| 242 | Genome-wide association study identifies multiple risk loci for renal cell carcinoma | 13.7 | 120 | Citations (PDF) |
| 243 | Dairy Food Intake and All-Cause, Cardiovascular Disease, and Cancer Mortality | 3.3 | 66 | Citations (PDF) |
| 244 | Mortality from respiratory diseases associated with opium use: a population-based cohort study | 5.6 | 27 | Citations (PDF) |
| 245 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer | 25.2 | 482 | Citations (PDF) |
| 246 | Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma | 16.8 | 45 | Citations (PDF) |
| 247 | Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction | 3.0 | 81 | Citations (PDF) |
| 248 | Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer | 14.4 | 336 | Citations (PDF) |
| 249 | Association analysis identifies 65 new breast cancer risk loci | 37.9 | 1,398 | Citations (PDF) |
| 250 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | 25.2 | 394 | Citations (PDF) |
| 251 | Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium | 4.3 | 22 | Citations (PDF) |
| 252 | RE: Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data | 4.6 | 1 | Citations (PDF) |
| 253 | Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium | 5.5 | 13 | Citations (PDF) |
| 254 | Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks | 3.8 | 91 | Citations (PDF) |
| 255 | Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma | 2.1 | 46 | Citations (PDF) |
| 256 | Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility | 13.7 | 44 | Citations (PDF) |
| 257 | Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population | 4.9 | 46 | Citations (PDF) |
| 258 | An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation | 4.8 | 216 | Citations (PDF) |
| 259 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers | 1.1 | 317 | Citations (PDF) |
| 260 | Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers | 4.6 | 291 | Citations (PDF) |
| 261 | Body mass index and breast cancer survival: a Mendelian randomization analysis | 4.9 | 53 | Citations (PDF) |
| 262 | Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer | 2.9 | 61 | Citations (PDF) |
| 263 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study | 4.8 | 45 | Citations (PDF) |
| 264 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent | 8.1 | 137 | Citations (PDF) |
| 265 | Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers | 2.3 | 12 | Citations (PDF) |
| 266 | Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study | 8.1 | 568 | Citations (PDF) |
| 267 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus | 2.3 | 12 | Citations (PDF) |
| 268 | Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study | 4.9 | 80 | Citations (PDF) |
| 269 | Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer | 4.3 | 53 | Citations (PDF) |
| 270 | Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk | 2.9 | 22 | Citations (PDF) |
| 271 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS | 3.8 | 204 | Citations (PDF) |
| 272 | Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium | 4.8 | 48 | Citations (PDF) |
| 273 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus | 4.8 | 37 | Citations (PDF) |
| 274 | Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry | 4.8 | 62 | Citations (PDF) |
| 275 | Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays | 1.0 | 11 | Citations (PDF) |
| 276 | Assessing the genetic architecture of epithelial ovarian cancer histological subtypes | 2.9 | 27 | Citations (PDF) |
| 277 | Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model | 4.2 | 87 | Citations (PDF) |
| 278 | Genetic predisposition to ductal carcinoma in situ of the breast | 4.8 | 54 | Citations (PDF) |
| 279 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry | 1.7 | 24 | Citations (PDF) |
| 280 | Five endometrial cancer risk loci identified through genome-wide association analysis | 25.2 | 90 | Citations (PDF) |
| 281 | The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin | 3.8 | 267 | Citations (PDF) |
| 282 | Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity | 5.5 | 19 | Citations (PDF) |
| 283 | Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study | 4.9 | 126 | Citations (PDF) |
| 284 | Risk Prediction for Epithelial Ovarian Cancer in 11 United States–Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci | 3.3 | 36 | Citations (PDF) |
| 285 | Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer | 9.7 | 84 | Citations (PDF) |
| 286 | Telomere structure and maintenance gene variants and risk of five cancer types | 4.3 | 52 | Citations (PDF) |
| 287 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression | 2.9 | 34 | Citations (PDF) |
| 288 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer | 1.1 | 80 | Citations (PDF) |
| 289 | Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis | 27.4 | 163 | Citations (PDF) |
| 290 | A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer | 4.3 | 10 | Citations (PDF) |
| 291 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types | 25.1 | 192 | Citations (PDF) |
| 292 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer | 13.7 | 103 | Citations (PDF) |
| 293 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus | 13.7 | 88 | Citations (PDF) |
| 294 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) | 3.4 | 21 | Citations (PDF) |
| 295 | Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation | 13.7 | 54 | Citations (PDF) |
| 296 | Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups | 4.8 | 66 | Citations (PDF) |
| 297 | The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes | 13.7 | 1,496 | Citations (PDF) |
| 298 | Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study | 1.7 | 2 | Citations (PDF) |
| 299 | New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study | 3.8 | 60 | Citations (PDF) |
| 300 | Household Fuel Use and Cardiovascular Disease Mortality | 18.1 | 73 | Citations (PDF) |
| 301 | Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer | 4.8 | 82 | Citations (PDF) |
| 302 | A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer | 1.1 | 79 | Citations (PDF) |
| 303 | Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors | 1.1 | 12 | Citations (PDF) |
| 304 | High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium | 3.3 | 19 | Citations (PDF) |
| 305 | GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer | 2.9 | 21 | Citations (PDF) |
| 306 | PPM1DMosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations | 4.6 | 47 | Citations (PDF) |
| 307 | The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies | 2.0 | 24 | Citations (PDF) |
| 308 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing | 3.8 | 100 | Citations (PDF) |
| 309 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 | 25.2 | 148 | Citations (PDF) |
| 310 | Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity | 6.8 | 17 | Citations (PDF) |
| 311 | Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer | 1.1 | 12 | Citations (PDF) |
| 312 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers | 4.6 | 81 | Citations (PDF) |
| 313 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer | 3.0 | 20 | Citations (PDF) |
| 314 | RAD51B in Familial Breast Cancer | 2.3 | 29 | Citations (PDF) |
| 315 | The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study | 2.3 | 16 | Citations (PDF) |
| 316 | Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors | 4.3 | 37 | Citations (PDF) |
| 317 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1 | 3.4 | 39 | Citations (PDF) |
| 318 | A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities | 7.1 | 29 | Citations (PDF) |
| 319 | Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk | 3.1 | 23 | Citations (PDF) |
| 320 | A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients | 2.9 | 10 | Citations (PDF) |
| 321 | Common germline polymorphisms associated with breast cancer-specific survival | 4.8 | 29 | Citations (PDF) |
| 322 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density | 4.8 | 22 | Citations (PDF) |
| 323 | Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis | 4.6 | 151 | Citations (PDF) |
| 324 | Prediction of individual genetic risk to prostate cancer using a polygenic score | 2.1 | 55 | Citations (PDF) |
| 325 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair | 0.5 | 0 | Citations (PDF) |
| 326 | Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling? | 2.4 | 20 | Citations (PDF) |
| 327 | The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran | 2.3 | 14 | Citations (PDF) |
| 328 | Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk | 2.3 | 47 | Citations (PDF) |
| 329 | Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening | 2.3 | 29 | Citations (PDF) |
| 330 | Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants | 4.6 | 482 | Citations (PDF) |
| 331 | PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes | 10.0 | 260 | Citations (PDF) |
| 332 | Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci | 2.9 | 47 | Citations (PDF) |
| 333 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium | 3.3 | 25 | Citations (PDF) |
| 334 | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer | 9.7 | 58 | Citations (PDF) |
| 335 | Germline Mutation in
BRCA1
or
BRCA2
and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer | 6.8 | 154 | Citations (PDF) |
| 336 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 | 2.9 | 40 | Citations (PDF) |
| 337 | A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer | 25.1 | 61 | Citations (PDF) |
| 338 | Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1 | 6.5 | 81 | Citations (PDF) |
| 339 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer | 2.8 | 18 | Citations (PDF) |
| 340 | A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer | 4.1 | 38 | Citations (PDF) |
| 341 | The effect of rare variants on inflation of the test statistics in case–control analyses | 3.0 | 8 | Citations (PDF) |
| 342 | 19. A review of PREDICT using the POSH cohort (women aged 40 years or younger at breast cancer diagnosis) | 0.9 | 0 | Citations (PDF) |
| 343 | Network-Based Integration of GWAS and Gene Expression Identifies a
HOX
-Centric Network Associated with Serous Ovarian Cancer Risk | 1.1 | 31 | Citations (PDF) |
| 344 | Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma | 25.2 | 236 | Citations (PDF) |
| 345 | Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium | 6.8 | 37 | Citations (PDF) |
| 346 | The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape | 8.5 | 160 | Citations (PDF) |
| 347 | Hereditary Diffuse Gastric Cancer Syndrome | 14.4 | 639 | Citations (PDF) |
| 348 | Identification of Novel Genetic Markers of Breast Cancer Survival | 4.6 | 65 | Citations (PDF) |
| 349 | Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci | 1.1 | 59 | Citations (PDF) |
| 350 | Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study | 3.0 | 18 | Citations (PDF) |
| 351 | Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions | 4.3 | 37 | Citations (PDF) |
| 352 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures | 3.8 | 59 | Citations (PDF) |
| 353 | Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer | 13.7 | 70 | Citations (PDF) |
| 354 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair | 25.2 | 417 | Citations (PDF) |
| 355 | Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer | 2.8 | 27 | Citations (PDF) |
| 356 | Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans | 2.9 | 76 | Citations (PDF) |
| 357 | A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects | 3.8 | 59 | Citations (PDF) |
| 358 | Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel—Response | 6.8 | 2 | Citations (PDF) |
| 359 | Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis | 7.1 | 57 | Citations (PDF) |
| 360 | Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer | 60.8 | 1,071 | Citations (PDF) |
| 361 | An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis | 5.5 | 37 | Citations (PDF) |
| 362 | Shared genetics underlying epidemiological association between endometriosis and ovarian cancer | 2.9 | 76 | Citations (PDF) |
| 363 | ClinGen and Genetic Testing | 34.6 | 8 | Citations (PDF) |
| 364 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization | 4.6 | 113 | Citations (PDF) |
| 365 | Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC | 5.5 | 44 | Citations (PDF) |
| 366 | Dietary intake of minerals and risk of esophageal squamous cell carcinoma: results from the Golestan Cohort Study | 4.7 | 70 | Citations (PDF) |
| 367 | Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer | 4.6 | 361 | Citations (PDF) |
| 368 | Genome-Wide Association Study of Prostate Cancer–Specific Survival | 1.1 | 28 | Citations (PDF) |
| 369 | Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk | 1.1 | 25 | Citations (PDF) |
| 370 | Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis | 4.2 | 91 | Citations (PDF) |
| 371 | Population Distribution of Lifetime Risk of Ovarian Cancer in the United States | 1.1 | 94 | Citations (PDF) |
| 372 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk | 2.9 | 39 | Citations (PDF) |
| 373 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk | 2.9 | 54 | Citations (PDF) |
| 374 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers | 5.5 | 9 | Citations (PDF) |
| 375 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium | 2.9 | 9 | Citations (PDF) |
| 376 | Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran | 2.6 | 31 | Citations (PDF) |
| 377 | Heart Disease Is Associated With Anthropometric Indices and Change in
Body Size Perception Over the Life Course: The Golestan Cohort Study | 2.5 | 4 | Citations (PDF) |
| 378 | Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC) | 0.0 | 27 | Citations (PDF) |
| 379 | Determinants of Gastroesophageal Reflux Disease, Including Hookah Smoking and Opium Use– A Cross-Sectional Analysis of 50,000 Individuals | 2.3 | 37 | Citations (PDF) |
| 380 | MicroRNA Related Polymorphisms and Breast Cancer Risk | 2.3 | 51 | Citations (PDF) |
| 381 | Educating doctors and patients about how conflicts of interest can affect healthcare decision making | 0.2 | 2 | Citations (PDF) |
| 382 | Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier | 8.1 | 99 | Citations (PDF) |
| 383 | Most common ‘sporadic’ cancers have a significant germline genetic component | 2.9 | 98 | Citations (PDF) |
| 384 | Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants | 3.8 | 76 | Citations (PDF) |
| 385 | Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study | 5.5 | 98 | Citations (PDF) |
| 386 | Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast | 3.2 | 44 | Citations (PDF) |
| 387 | Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer | 3.2 | 35 | Citations (PDF) |
| 388 | What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer? | 2.3 | 18 | Citations (PDF) |
| 389 | Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer | 1.1 | 14 | Citations (PDF) |
| 390 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy | 13.7 | 16 | Citations (PDF) |
| 391 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium | 2.9 | 57 | Citations (PDF) |
| 392 | Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients | 10.0 | 708 | Citations (PDF) |
| 393 | Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer | 2.9 | 57 | Citations (PDF) |
| 394 | Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | 4.8 | 110 | Citations (PDF) |
| 395 | Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues | 2.0 | 50 | Citations (PDF) |
| 396 | Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with
IL1A
and
TNFSF10 | 3.8 | 57 | Citations (PDF) |
| 397 | Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome | 4.2 | 25 | Citations (PDF) |
| 398 | Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel | 6.8 | 101 | Citations (PDF) |
| 399 | The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length | 4.6 | 111 | Citations (PDF) |
| 400 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium | 2.9 | 34 | Citations (PDF) |
| 401 | Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran | 5.3 | 34 | Citations (PDF) |
| 402 | A Genome-wide Association Study of Early-Onset Breast Cancer Identifies
PFKM
as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age | 1.1 | 84 | Citations (PDF) |
| 403 | The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population | 2.9 | 128 | Citations (PDF) |
| 404 | Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions | 3.1 | 28 | Citations (PDF) |
| 405 | Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk | 4.0 | 18 | Citations (PDF) |
| 406 | Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases | 1.1 | 46 | Citations (PDF) |
| 407 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium | 5.5 | 22 | Citations (PDF) |
| 408 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche | 37.9 | 620 | Citations (PDF) |
| 409 | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer | 25.2 | 432 | Citations (PDF) |
| 410 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation | 13.7 | 110 | Citations (PDF) |
| 411 | Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer | 2.0 | 18 | Citations (PDF) |
| 412 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade | 2.9 | 13 | Citations (PDF) |
| 413 | A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity | 2.0 | 143 | Citations (PDF) |
| 414 | Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types | 2.9 | 73 | Citations (PDF) |
| 415 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study | 4.8 | 14 | Citations (PDF) |
| 416 | Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2 and RAD51C Status | 3.4 | 134 | Citations (PDF) |
| 417 | Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition | 2.9 | 14 | Citations (PDF) |
| 418 | Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk | 2.9 | 35 | Citations (PDF) |
| 419 | Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals | 16.8 | 120 | Citations (PDF) |
| 420 | The admixture maximum likelihood test to test for association between rare variants and disease phenotypes | 3.0 | 14 | Citations (PDF) |
| 421 | Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study | 27.4 | 392 | Citations (PDF) |
| 422 | Inherited Genetic Susceptibility to Breast Cancer | 3.4 | 86 | Citations (PDF) |
| 423 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer | 25.2 | 347 | Citations (PDF) |
| 424 | Opium Use and Risk of Mortality from Digestive Diseases: A Prospective Cohort Study | 0.7 | 53 | Citations (PDF) |
| 425 | Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial | 4.3 | 15 | Citations (PDF) |
| 426 | Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1 | 6.5 | 104 | Citations (PDF) |
| 427 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | 25.2 | 514 | Citations (PDF) |
| 428 | Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer | 4.8 | 356 | Citations (PDF) |
| 429 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression | 2.9 | 2 | Citations (PDF) |
| 430 | Science is like a vast jigsaw | 0.2 | 0 | Citations (PDF) |
| 431 | Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers | 6.5 | 209 | Citations (PDF) |
| 432 | Astronomical algorithms for automated analysis of tissue protein expression in breast cancer | 5.5 | 32 | Citations (PDF) |
| 433 | Genome-wide association studies identify four ER negative–specific breast cancer risk loci | 25.2 | 396 | Citations (PDF) |
| 434 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array | 25.2 | 516 | Citations (PDF) |
| 435 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk | 25.2 | 1,020 | Citations (PDF) |
| 436 | Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls | 2.9 | 90 | Citations (PDF) |
| 437 | Incorporating genomics into breast and prostate cancer screening: assessing the implications | 4.2 | 85 | Citations (PDF) |
| 438 | Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran | 4.0 | 45 | Citations (PDF) |
| 439 | A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus | 25.2 | 185 | Citations (PDF) |
| 440 | Polymorphisms in Inflammation Pathway Genes and Endometrial Cancer Risk | 1.1 | 23 | Citations (PDF) |
| 441 | Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk | 3.2 | 114 | Citations (PDF) |
| 442 | Cost effectiveness of the NHS breast screening programme: life table model | 0.2 | 76 | Citations (PDF) |
| 443 | Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors | 3.2 | 142 | Citations (PDF) |
| 444 | The US Office for Human Research Protections' judgment of the SUPPORT trial seems entirely reasonable | 0.2 | 7 | Citations (PDF) |
| 445 | A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk | 2.9 | 141 | Citations (PDF) |
| 446 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression | 2.9 | 105 | Citations (PDF) |
| 447 | Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer | 1.1 | 58 | Citations (PDF) |
| 448 | Public health genomics and personalized prevention: lessons from the COGS project | 7.3 | 28 | Citations (PDF) |
| 449 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer | 13.7 | 154 | Citations (PDF) |
| 450 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 | 13.7 | 107 | Citations (PDF) |
| 451 | A U-shaped relationship between haematocrit and mortality in a large prospective cohort study | 4.9 | 31 | Citations (PDF) |
| 452 | Outside the Box: Proactive care: the patient’s right to choose | 1.2 | 0 | Citations (PDF) |
| 453 | Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression | 2.4 | 19 | Citations (PDF) |
| 454 | Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA | 2.9 | 24 | Citations (PDF) |
| 455 | Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer | 3.0 | 34 | Citations (PDF) |
| 456 | Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer | 2.3 | 22 | Citations (PDF) |
| 457 | Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial and Re: CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients | 4.6 | 36 | Citations (PDF) |
| 458 | Gene Set Analysis of Survival Following Ovarian Cancer Implicates Macrolide Binding and Intracellular Signaling Genes | 1.1 | 7 | Citations (PDF) |
| 459 | Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran | 0.2 | 151 | Citations (PDF) |
| 460 | Population-based Screening in the Era of Genomics | 1.3 | 23 | Citations (PDF) |
| 461 | PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 | 5.5 | 184 | Citations (PDF) |
| 462 | Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials | 5.5 | 16 | Citations (PDF) |
| 463 | Common Variants at the 19p13.1 and
ZNF365
Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in
BRCA1
and
BRCA2
Mutation Carriers | 1.1 | 52 | Citations (PDF) |
| 464 | Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13 | 2.9 | 19 | Citations (PDF) |
| 465 | The role of genetic breast cancer susceptibility variants as prognostic factors | 2.9 | 83 | Citations (PDF) |
| 466 | The Potential for Risk Stratification in the Management of Ovarian Cancer Risk | 2.7 | 9 | Citations (PDF) |
| 467 | Why the victims were silent | 0.2 | 0 | Citations (PDF) |
| 468 | Any conclusion from this "citizens' jury" will be seriously flawed | 0.2 | 0 | Citations (PDF) |
| 469 | Association Between <emph type="ital">BRCA1</emph> and <emph type="ital">BRCA2</emph> Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer | 16.6 | 620 | Citations (PDF) |
| 470 | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk | 25.2 | 104 | Citations (PDF) |
| 471 | Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study | 27.4 | 218 | Citations (PDF) |
| 472 | ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium | 1.7 | 36 | Citations (PDF) |
| 473 | Standardized Total Average Toxicity Score: A Scale- and Grade-Independent Measure of Late Radiotherapy Toxicity to Facilitate Pooling of Data From Different Studies | 1.5 | 66 | Citations (PDF) |
| 474 | Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk | 25.2 | 216 | Citations (PDF) |
| 475 | Genome-wide association analysis identifies three new breast cancer susceptibility loci | 25.2 | 271 | Citations (PDF) |
| 476 | TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer | 13.7 | 102 | Citations (PDF) |
| 477 | 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium | 1.1 | 17 | Citations (PDF) |
| 478 | Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer | 5.5 | 62 | Citations (PDF) |
| 479 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11 | 2.9 | 173 | Citations (PDF) |
| 480 | Genetic Variants in ER Cofactor Genes and Endometrial Cancer Risk | 2.3 | 4 | Citations (PDF) |
| 481 | Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 | 2.3 | 12 | Citations (PDF) |
| 482 | Neither off the peg nor made to measure calculations are fit for purpose | 0.2 | 0 | Citations (PDF) |
| 483 | A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER‐positive breast cancer | 4.9 | 71 | Citations (PDF) |
| 484 | A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23 | 2.9 | 84 | Citations (PDF) |
| 485 | Biological and prognostic associations of
miR‐205
and
let‐7b
in breast cancer revealed by
in situ
hybridization analysis of micro‐RNA expression in arrays of archival tumour tissue | 4.9 | 73 | Citations (PDF) |
| 486 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer | 4.5 | 36 | Citations (PDF) |
| 487 | The prognostic significance of lymphovascular invasion in invasive breast carcinoma | 4.0 | 230 | Citations (PDF) |
| 488 | The clonal and mutational evolution spectrum of primary triple-negative breast cancers | 37.9 | 1,901 | Citations (PDF) |
| 489 | PREDICT Plus: a population-based validation of a prognostic model for early breast cancer that includes HER2 | 2.3 | 4 | Citations (PDF) |
| 490 | Ovarian cancer susceptibility alleles and risk of ovarian cancer inBRCA1andBRCA2mutation carriers | 4.5 | 35 | Citations (PDF) |
| 491 | Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) | 2.3 | 52 | Citations (PDF) |
| 492 | Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer | 1.1 | 27 | Citations (PDF) |
| 493 | Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies | 4.6 | 626 | Citations (PDF) |
| 494 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium | 2.9 | 156 | Citations (PDF) |
| 495 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer | 25.2 | 296 | Citations (PDF) |
| 496 | Diabetes Mellitus and Its Correlates in an Iranian Adult Population | 2.3 | 71 | Citations (PDF) |
| 497 | A population-based validation of the prognostic model PREDICT for early breast cancer | 0.9 | 114 | Citations (PDF) |
| 498 | Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 | 4.8 | 76 | Citations (PDF) |
| 499 | Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance | 4.8 | 94 | Citations (PDF) |
| 500 | Money is the greatest conflict of all | 0.1 | 0 | Citations (PDF) |
| 501 | Balancing probabilities | 0.1 | 0 | Citations (PDF) |
| 502 | Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers | 2.3 | 52 | Citations (PDF) |
| 503 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer | 25.2 | 149 | Citations (PDF) |
| 504 | Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer | 5.5 | 63 | Citations (PDF) |
| 505 | Polygenic susceptibility to prostate and breast cancer: implications for personalised screening | 5.5 | 164 | Citations (PDF) |
| 506 | Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England | 5.5 | 39 | Citations (PDF) |
| 507 | Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study | 3.0 | 28 | Citations (PDF) |
| 508 | Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testing | 3.0 | 0 | Citations (PDF) |
| 509 | A role for XRCC2 gene polymorphisms in breast cancer risk and survival | 3.8 | 48 | Citations (PDF) |
| 510 | Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript | 2.9 | 87 | Citations (PDF) |
| 511 | Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development | 1.8 | 36 | Citations (PDF) |
| 512 | A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival | 2.9 | 20 | Citations (PDF) |
| 513 | Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests | 1.7 | 4 | Citations (PDF) |
| 514 | Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium | 4.3 | 51 | Citations (PDF) |
| 515 | PSA‐detected prostate cancer and the potential for dedifferentiation—estimating the proportion capable of progression | 4.3 | 18 | Citations (PDF) |
| 516 | Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer | 4.3 | 55 | Citations (PDF) |
| 517 | Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence | 2.0 | 4 | Citations (PDF) |
| 518 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study | 25.2 | 278 | Citations (PDF) |
| 519 | Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers | 2.9 | 70 | Citations (PDF) |
| 520 | Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk | 2.9 | 23 | Citations (PDF) |
| 521 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium† | 2.9 | 73 | Citations (PDF) |
| 522 | TGF-β Signaling Pathway and Breast Cancer Susceptibility | 1.1 | 53 | Citations (PDF) |
| 523 | The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing | 6.8 | 48 | Citations (PDF) |
| 524 | 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium | 3.8 | 5 | Citations (PDF) |
| 525 | LIN28B
Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer | 3.8 | 78 | Citations (PDF) |
| 526 | Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers | 2.9 | 37 | Citations (PDF) |
| 527 | Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer | 3.8 | 114 | Citations (PDF) |
| 528 | A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma | 37.9 | 452 | Citations (PDF) |
| 529 | Re: Promoting Healthy Skepticism in the News: Helping Journalists Get It Right | 4.6 | 1 | Citations (PDF) |
| 530 | Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults | 1.3 | 19 | Citations (PDF) |
| 531 | Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers | 4.6 | 42 | Citations (PDF) |
| 532 | KRAS rs61764370 in Epithelial Ovarian Cancer–Response | 6.8 | 1 | Citations (PDF) |
| 533 | Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study | 2.8 | 6 | Citations (PDF) |
| 534 | Multiple Common Susceptibility Variants near BMP Pathway Loci GREM1, BMP4, and BMP2 Explain Part of the Missing Heritability of Colorectal Cancer | 3.2 | 197 | Citations (PDF) |
| 535 | Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium | 2.3 | 5 | Citations (PDF) |
| 536 | Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium | 2.3 | 22 | Citations (PDF) |
| 537 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study | 4.8 | 86 | Citations (PDF) |
| 538 | Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study | 0.1 | 291 | Citations (PDF) |
| 539 | Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival | 3.0 | 29 | Citations (PDF) |
| 540 | BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | 5.5 | 293 | Citations (PDF) |
| 541 | A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants | 5.5 | 120 | Citations (PDF) |
| 542 | Genome-wide association study identifies five new breast cancer susceptibility loci | 25.2 | 669 | Citations (PDF) |
| 543 | Common variants at 19p13 are associated with susceptibility to ovarian cancer | 25.2 | 250 | Citations (PDF) |
| 544 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 | 25.2 | 339 | Citations (PDF) |
| 545 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population | 25.2 | 317 | Citations (PDF) |
| 546 | Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33 | 25.2 | 344 | Citations (PDF) |
| 547 | Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies | 25.2 | 476 | Citations (PDF) |
| 548 | Verbal Autopsy: Reliability and Validity Estimates for Causes of Death in the Golestan Cohort Study in Iran | 2.3 | 89 | Citations (PDF) |
| 549 | Risk Factors for Breast Cancer | 2.8 | 31 | Citations (PDF) |
| 550 | A Genome-Wide Association Study of Prognosis in Breast Cancer | 1.1 | 59 | Citations (PDF) |
| 551 | Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium | 1.1 | 24 | Citations (PDF) |
| 552 | No Association between TERT-CLPTM1L Single Nucleotide Polymorphism rs401681 and Mean Telomere Length or Cancer Risk | 1.1 | 40 | Citations (PDF) |
| 553 | Genetic Variation in
TYMS
in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association Consortium | 1.1 | 25 | Citations (PDF) |
| 554 | Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies | 1.1 | 56 | Citations (PDF) |
| 555 | Telomere Length in Prospective and Retrospective Cancer Case-Control Studies | 3.8 | 148 | Citations (PDF) |
| 556 | Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls | 1.1 | 36 | Citations (PDF) |
| 557 | Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot” | 3.2 | 50 | Citations (PDF) |
| 558 | Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies | 8.1 | 826 | Citations (PDF) |
| 559 | ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study | 1.1 | 89 | Citations (PDF) |
| 560 | Association Between a Germline OCA2 Polymorphism at Chromosome 15q13.1 and Estrogen Receptor–Negative Breast Cancer Survival | 4.6 | 51 | Citations (PDF) |
| 561 | Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations | 1.1 | 28 | Citations (PDF) |
| 562 | A genome-wide association scan on estrogen receptor-negative breast cancer | 4.8 | 35 | Citations (PDF) |
| 563 | A Prospective, Multicenter Study to Evaluate a Novel, Nonendoscopic Screening Device for Barrett's Esophagus in the Community Setting | 0.9 | 0 | Citations (PDF) |
| 564 | Fine scale mapping of the breast cancer 16q12 locus | 2.9 | 71 | Citations (PDF) |
| 565 | The inherited genetics of ovarian and endometrial cancer | 3.2 | 68 | Citations (PDF) |
| 566 | Common germ-line polymorphism of C1QA and breast cancer survival | 5.5 | 21 | Citations (PDF) |
| 567 | No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: Results from the RAPPER study | 2.0 | 54 | Citations (PDF) |
| 568 | Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601) | 27.4 | 125 | Citations (PDF) |
| 569 | CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen | 4.8 | 80 | Citations (PDF) |
| 570 | PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer | 4.8 | 356 | Citations (PDF) |
| 571 | Familial relative risks for breast cancer by pathological subtype: a population-based cohort study | 4.8 | 35 | Citations (PDF) |
| 572 | Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 | 25.2 | 226 | Citations (PDF) |
| 573 | A combined analysis of genome-wide association studies in breast cancer | 2.4 | 92 | Citations (PDF) |
| 574 | Polygenic Susceptibility to Breast Cancer: Current State-of-The-Art | 2.3 | 40 | Citations (PDF) |
| 575 | Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening | 5.5 | 67 | Citations (PDF) |
| 576 | Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study | 2.9 | 44 | Citations (PDF) |
| 577 | Association of ESR1 gene tagging SNPs with breast cancer risk | 2.9 | 87 | Citations (PDF) |
| 578 | Stage Shift in Psa-detected Prostate Cancers – Effect Modification by Gleason Score | 2.0 | 19 | Citations (PDF) |
| 579 | Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042 | 4.6 | 101 | Citations (PDF) |
| 580 | Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival | 2.9 | 19 | Citations (PDF) |
| 581 | Common Genetic Variation in Candidate Genes and Susceptibility to Subtypes of Breast Cancer | 1.1 | 52 | Citations (PDF) |
| 582 | FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation | 2.9 | 114 | Citations (PDF) |
| 583 | Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer | 4.3 | 17 | Citations (PDF) |
| 584 | Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer | 4.3 | 34 | Citations (PDF) |
| 585 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 | 25.2 | 445 | Citations (PDF) |
| 586 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 | 25.2 | 296 | Citations (PDF) |
| 587 | p53 polymorphisms: cancer implications | 60.8 | 599 | Citations (PDF) |
| 588 | Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype | 60.8 | 682 | Citations (PDF) |
| 589 | Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium | 5.5 | 49 | Citations (PDF) |
| 590 | Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer | 5.5 | 25 | Citations (PDF) |
| 591 | Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates? | 5.5 | 62 | Citations (PDF) |
| 592 | Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival | 5.5 | 81 | Citations (PDF) |
| 593 | Role of genetic polymorphisms and ovarian cancer susceptibility | 4.1 | 70 | Citations (PDF) |
| 594 | Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium | 1.1 | 59 | Citations (PDF) |
| 595 | Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients | 4.8 | 37 | Citations (PDF) |
| 596 | Variation in genes required for normal mitosis and risk of breast cancer | 2.4 | 32 | Citations (PDF) |
| 597 | COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer | 5.5 | 44 | Citations (PDF) |
| 598 | Association between Common Germline Genetic Variation in 94 Candidate Genes or Regions and Risks of Invasive Epithelial Ovarian Cancer | 2.3 | 38 | Citations (PDF) |
| 599 | Haplotypes of the estrogen receptor beta gene and breast cancer risk | 4.3 | 40 | Citations (PDF) |
| 600 | Consortium analysis of 7 candidate SNPs for ovarian cancer | 4.3 | 79 | Citations (PDF) |
| 601 | Common Single-Nucleotide Polymorphisms in DNA Double-Strand Break Repair Genes and Breast Cancer Risk | 1.1 | 33 | Citations (PDF) |
| 602 | Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis | 5.5 | 51 | Citations (PDF) |
| 603 | The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions | 5.5 | 490 | Citations (PDF) |
| 604 | A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 | 25.2 | 521 | Citations (PDF) |
| 605 | Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 | 25.2 | 553 | Citations (PDF) |
| 606 | Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer | 25.2 | 506 | Citations (PDF) |
| 607 | Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer | 2.9 | 168 | Citations (PDF) |
| 608 | Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients | 2.3 | 378 | Citations (PDF) |
| 609 | Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies | 4.8 | 44 | Citations (PDF) |
| 610 | Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort | 4.8 | 34 | Citations (PDF) |
| 611 | Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients | 4.9 | 21 | Citations (PDF) |
| 612 | Cell type-specific DNA methylation patterns in the human breast | 7.5 | 211 | Citations (PDF) |
| 613 | Common variants in mismatch repair genes and risk of colorectal cancer | 16.8 | 47 | Citations (PDF) |
| 614 | Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer | 2.9 | 126 | Citations (PDF) |
| 615 | Association of a Common AKAP9 Variant With Breast Cancer Risk: A Collaborative Analysis | 4.6 | 49 | Citations (PDF) |
| 616 | Identification of Common Variants in the SHBG Gene Affecting Sex Hormone-Binding Globulin Levels and Breast Cancer Risk in Postmenopausal Women | 1.1 | 56 | Citations (PDF) |
| 617 | Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer | 34.6 | 567 | Citations (PDF) |
| 618 | Risk Factors for the Incidence of Breast Cancer: Do They Affect Survival From the Disease? | 16.9 | 181 | Citations (PDF) |
| 619 | Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics | 3.2 | 324 | Citations (PDF) |
| 620 | Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population | 2.8 | 71 | Citations (PDF) |
| 621 | HSD17B1 Genetic Variants and Hormone Receptor–Defined Breast Cancer | 1.1 | 11 | Citations (PDF) |
| 622 | Multiple Loci With Different Cancer Specificities Within the 8q24 Gene Desert | 4.6 | 309 | Citations (PDF) |
| 623 | Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics | 3.8 | 177 | Citations (PDF) |
| 624 | Association between Common Variation in 120 Candidate Genes and Breast Cancer Risk | 3.2 | 137 | Citations (PDF) |
| 625 | Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from Two Australian Studies and an Additional Validation Set | 1.1 | 67 | Citations (PDF) |
| 626 | Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer | 16.6 | 412 | Citations (PDF) |
| 627 | Cancer genetics of epigenetic genes | 2.9 | 230 | Citations (PDF) |
| 628 | How Not to Interpret a P Value? | 4.6 | 12 | Citations (PDF) |
| 629 | Common Germline Genetic Variation in Antioxidant Defense Genes and Survival After Diagnosis of Breast Cancer | 16.9 | 104 | Citations (PDF) |
| 630 | Turning the Pump Handle: Evolving Methods for Integrating the Evidence on Gene-Disease Association | 3.3 | 27 | Citations (PDF) |
| 631 | Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer | 3.8 | 81 | Citations (PDF) |
| 632 | Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk | 7.5 | 64 | Citations (PDF) |
| 633 | Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk | 4.8 | 100 | Citations (PDF) |
| 634 | Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer | 2.3 | 56 | Citations (PDF) |
| 635 | Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer | 4.5 | 81 | Citations (PDF) |
| 636 | Screening for theBRCA1-ins6kbEx13mutation: potential for misdiagnosis | 4.5 | 9 | Citations (PDF) |
| 637 | A common coding variant in CASP8 is associated with breast cancer risk | 25.2 | 602 | Citations (PDF) |
| 638 | Common variants in WFS1 confer risk of type 2 diabetes | 25.2 | 346 | Citations (PDF) |
| 639 | Genome-wide association study identifies novel breast cancer susceptibility loci | 37.9 | 2,211 | Citations (PDF) |
| 640 | A common variant of the p16INK4a genetic region is associated with physical function in older people | 4.7 | 84 | Citations (PDF) |
| 641 | The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study | 2.4 | 50 | Citations (PDF) |
| 642 | Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysis | 4.9 | 398 | Citations (PDF) |
| 643 | BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives | 4.9 | 154 | Citations (PDF) |
| 644 | Interactions between genes involved in the antioxidant defence system and breast cancer risk | 5.5 | 30 | Citations (PDF) |
| 645 | HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer | 5.5 | 36 | Citations (PDF) |
| 646 | Evaluation of an algorithm of tagging SNPs selection by linkage disequilibrium | 1.8 | 11 | Citations (PDF) |
| 647 | Pharmacogenetics of cancer chemotherapy | 7.0 | 22 | Citations (PDF) |
| 648 | The admixture maximum likelihood test: a novel experiment‐wise test of association between disease and multiple SNPs | 3.1 | 32 | Citations (PDF) |
| 649 | IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer | 2.9 | 182 | Citations (PDF) |
| 650 | BRCA1 and BRCA2 Cancer Risks | 16.9 | 27 | Citations (PDF) |
| 651 | Common variants in mismatch repair genes and risk of invasive ovarian cancer | 2.8 | 71 | Citations (PDF) |
| 652 | Prognostic Value of PAI1 in Invasive Breast Cancer: Evidence That Tumor-Specific Factors Are More Important Than Genetic Variation in Regulating PAI1 Expression | 1.1 | 66 | Citations (PDF) |
| 653 | BRCA1 Suppresses Osteopontin-mediated Breast Cancer | 2.2 | 28 | Citations (PDF) |
| 654 | Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population | 5.5 | 11 | Citations (PDF) |
| 655 | Genetic variants in epigenetic genes and breast cancer risk | 2.8 | 87 | Citations (PDF) |
| 656 | Association of the Progesterone Receptor Gene with Breast Cancer Risk: A Single-Nucleotide Polymorphism Tagging Approach | 1.1 | 56 | Citations (PDF) |
| 657 | Five Glutathione S-Transferase Gene Variants in 23,452 Cases of Lung Cancer and 30,397 Controls: Meta-Analysis of 130 Studies | 8.1 | 129 | Citations (PDF) |
| 658 | Polygenic Inherited Predisposition to Breast Cancer | 1.6 | 27 | Citations (PDF) |
| 659 | Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1 | 25.2 | 174 | Citations (PDF) |
| 660 | Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs | 2.9 | 14 | Citations (PDF) |
| 661 | Polymorphisms in DNA repair genes and epithelial ovarian cancer risk | 4.3 | 130 | Citations (PDF) |
| 662 | Identification and validation of prognostic markers in breast cancer with the complementary use of array‐CGH and tissue microarrays | 4.9 | 138 | Citations (PDF) |
| 663 | Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer | 3.2 | 66 | Citations (PDF) |
| 664 | Genetic variation in the HSD17B1 gene and risk of prostate cancer | 3.2 | 7 | Citations (PDF) |
| 665 | Common Polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not Associated with Breast Cancer Risk | 1.1 | 23 | Citations (PDF) |
| 666 | Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer | 2.8 | 42 | Citations (PDF) |
| 667 | Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer | 2.9 | 71 | Citations (PDF) |
| 668 | Polymorphisms in the Initiators of RET (Rearranged during Transfection) Signaling Pathway and Susceptibility to Sporadic Medullary Thyroid Carcinoma | 4.1 | 77 | Citations (PDF) |
| 669 | Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study | 4.8 | 56 | Citations (PDF) |
| 670 | Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations | 5.5 | 142 | Citations (PDF) |
| 671 | Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women | 4.6 | 313 | Citations (PDF) |
| 672 | Association studies for finding cancer-susceptibility genetic variants | 60.8 | 422 | Citations (PDF) |
| 673 | The BOADICEA model of genetic susceptibility to breast and ovarian cancer | 5.5 | 441 | Citations (PDF) |
| 674 | Model of the early development of diffuse gastric cancer in E‐cadherin mutation carriers and its implications for patient screening | 4.9 | 250 | Citations (PDF) |
| 675 | Association of a Common Variant of the CASP8 Gene With Reduced Risk of Breast Cancer | 4.6 | 194 | Citations (PDF) |
| 676 | Thepatched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk | 4.3 | 67 | Citations (PDF) |
| 677 | A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma | 0.9 | 464 | Citations (PDF) |
| 678 | Prediction of pathogenic mutations in patients with early-onset breast cancer by family history | 62.3 | 206 | Citations (PDF) |
| 679 | Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies | 6.5 | 3,309 | Citations (PDF) |
| 680 | Issues of consent and feedback in a genetic epidemiological study of women with breast cancer | 2.3 | 51 | Citations (PDF) |
| 681 | Re: On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance | 4.6 | 7 | Citations (PDF) |
| 682 | Molecular Classification of Breast Carcinomas Using Tissue Microarrays | 1.4 | 158 | Citations (PDF) |
| 683 | A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes | 5.5 | 439 | Citations (PDF) |
| 684 | Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma | 4.6 | 580 | Citations (PDF) |
| 685 | Variants in DNA double-strand break repair genes and breast cancer susceptibility | 2.9 | 337 | Citations (PDF) |
| 686 | The genetics of ovarian cancer | 3.8 | 63 | Citations (PDF) |
| 687 | BRCA1 and BRCA2 mutations in Russian familial breast cancer | 4.5 | 36 | Citations (PDF) |
| 688 | Polygenic susceptibility to breast cancer and implications for prevention | 25.2 | 896 | Citations (PDF) |
| 689 | Title is missing! 2002 | | 3 | Citations (PDF) |
| 690 | Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma | 0.9 | 409 | Citations (PDF) |
| 691 | Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families | 0.9 | 612 | Citations (PDF) |
| 692 | BRCA1 and BRCA2 mutations in a population-based study of male breast cancer | 4.8 | 158 | Citations (PDF) |
| 693 | Degenerate Oligonucleotide Primed-Polymerase Chain Reaction-Based Array Comparative Genomic Hybridization for Extensive Amplicon Profiling of Breast Cancers | 3.4 | 98 | Citations (PDF) |
| 694 | Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations | 0.9 | 40 | Citations (PDF) |
| 695 | Apparent humanBRCA1 knockout caused by mispriming during polymerase chain reaction: Implications for genetic testing | 3.0 | 29 | Citations (PDF) |
| 696 | Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study | 3.1 | 268 | Citations (PDF) |
| 697 | Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk | 2.8 | 48 | Citations (PDF) |
| 698 | Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer | 4.3 | 69 | Citations (PDF) |
| 699 | Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers | 4.3 | 86 | Citations (PDF) |
| 700 | An analysis of ovarian tumor diameter and survival | 2.7 | 7 | Citations (PDF) |
| 701 | A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability | 25.2 | 152 | Citations (PDF) |
| 702 | Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk | 2.8 | 76 | Citations (PDF) |
| 703 | Familial predisposition to breast cancer in a British population | 4.9 | 42 | Citations (PDF) |
| 704 | No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer | 2.8 | 103 | Citations (PDF) |
| 705 | Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis | 5.5 | 276 | Citations (PDF) |
| 706 | Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours 1999, 25, 91-96 | | 70 | Citations (PDF) |
| 707 | Title is missing! | 3.1 | 33 | Citations (PDF) |
| 708 | A systematic review and meta‐analysis of family history and risk of ovarian cancer | 3.1 | 220 | Citations (PDF) |
| 709 | Absolute risk of breast cancer in women at increased risk: a more useful clinical measure than relative risk? | 2.3 | 17 | Citations (PDF) |
| 710 | A follow-up study of new users of a university counselling service | 1.6 | 13 | Citations (PDF) |
| 711 | No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer | 5.5 | 88 | Citations (PDF) |
| 712 | Screening for breast and ovarian cancer: the relevance of family history | 4.0 | 27 | Citations (PDF) |
| 713 | Family history and the risk of breast cancer: A systematic review and meta-analysis | 4.3 | 522 | Citations (PDF) |
| 714 | Selective or universal neonatal BCG immunization: what policy for adistrict with a high incidence of tuberculosis? | 2.6 | 11 | Citations (PDF) |
| 715 | Health promotion in primary care: modelling the impact of intervention on coronary heart disease and stroke | 2.0 | 10 | Citations (PDF) |
| 716 | Vitamin A supplementation in preschool children with acute diarrhoea | 0.1 | 0 | Citations (PDF) |
| 717 | Health promotion in general practice | 0.1 | 1 | Citations (PDF) |
| 718 | Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts | 0.1 | 181 | Citations (PDF) |
| 719 | Care of men with cancer-predisposingBRCAvariants | 0.2 | 2 | Citations (PDF) |
| 720 | Title is missing! 0 | | 3 | Citations (PDF) |
| 721 | Using gene-environment interactions to explore pathways for colorectal cancer risk | 9.7 | 1 | Citations (PDF) |
| 722 | Evaluating breast cancer screening consortium and MammoRisk plus polygenic risk score 313 for breast cancer risk prediction in UK Biobank | 4.9 | 0 | Citations (PDF) |
